Health Care • Industrial Specialties
$6.42 ▲ +0.32
(+5.25%)
MKT CAP: $625.9M • VOL: 2.82M
52W L $3 52W H $11
ROARABLE / RQD
D- • 36/100
PIOTROSKI
2 / 9
AVR // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 |
|---|---|---|
| Revenue (Total Sales) | $1.9M | $2.7M |
| YoY Revenue Growth % | -29.2% | — |
| Gross Profit | $1.3M | $1.3M |
| Gross Margin % | 70.3% | 46.8% |
| Research & Development (R&D) | — | — |
| Operating Income (EBIT) | -$93.9M | -$78.4M |
| Operating Margin % | -80.0% | -80.0% |
| Net Income (GAAP) | -$94.1M | -$76.3M |
| EBITDA (Normalized) | -$92.3M | -$76.6M |
| Diluted EPS ($/sh) | — | — |
| Operating Cash Flow (OCF) | -$77.8M | -$61.2M |
| Capital Expenditures (CapEx) | $2.0M | $2.3M |
| Free Cash Flow (FCF) | -$79.8M | -$63.5M |
| FCF Margin % | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% |
| Cash & Short-Term Equivalents | $6.7M | $70.5M |
| Total Debt (Short + Long Term) | — | — |
| Total Stockholders' Equity | -$93.0K | $62.8M |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR AVR.